Poxel S.A. (OTCMKTS:PXXLF) Sees Large Increase in Short Interest

Poxel S.A. (OTCMKTS:PXXLF) saw a significant increase in short interest in the month of July. As of July 31st, there was short interest totalling 2,000 shares, an increase of 1,900.0% from the July 15th total of 100 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

Poxel Price Performance

Shares of Poxel stock remained flat at $0.70 during trading on Monday. The business has a 50-day simple moving average of $0.70 and a two-hundred day simple moving average of $0.64. Poxel has a twelve month low of $0.55 and a twelve month high of $0.70.

Poxel Company Profile

Poxel SA, a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan.